HXN6005

· Helixon Biotechnology (Suzhou) Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HXN6005, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of HXN6005 in Adult Healthy Participants [Phase 1]